1. Home
  2. RDHL vs CTCX Comparison

RDHL vs CTCX Comparison

Compare RDHL & CTCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • CTCX
  • Stock Information
  • Founded
  • RDHL 2009
  • CTCX 2007
  • Country
  • RDHL Israel
  • CTCX United States
  • Employees
  • RDHL N/A
  • CTCX N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • CTCX Medical/Dental Instruments
  • Sector
  • RDHL Health Care
  • CTCX Health Care
  • Exchange
  • RDHL Nasdaq
  • CTCX Nasdaq
  • Market Cap
  • RDHL 11.2M
  • CTCX 10.4M
  • IPO Year
  • RDHL N/A
  • CTCX N/A
  • Fundamental
  • Price
  • RDHL $7.08
  • CTCX $0.23
  • Analyst Decision
  • RDHL
  • CTCX
  • Analyst Count
  • RDHL 0
  • CTCX 0
  • Target Price
  • RDHL N/A
  • CTCX N/A
  • AVG Volume (30 Days)
  • RDHL 14.3K
  • CTCX 1.3M
  • Earning Date
  • RDHL 11-19-2024
  • CTCX 11-22-2024
  • Dividend Yield
  • RDHL N/A
  • CTCX N/A
  • EPS Growth
  • RDHL N/A
  • CTCX N/A
  • EPS
  • RDHL N/A
  • CTCX N/A
  • Revenue
  • RDHL $3,707,000.00
  • CTCX $12,320.00
  • Revenue This Year
  • RDHL $224.90
  • CTCX N/A
  • Revenue Next Year
  • RDHL $82.69
  • CTCX N/A
  • P/E Ratio
  • RDHL N/A
  • CTCX N/A
  • Revenue Growth
  • RDHL N/A
  • CTCX N/A
  • 52 Week Low
  • RDHL $6.80
  • CTCX $0.20
  • 52 Week High
  • RDHL $82.00
  • CTCX $4.31
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 29.71
  • CTCX 36.41
  • Support Level
  • RDHL $7.98
  • CTCX $0.25
  • Resistance Level
  • RDHL $7.36
  • CTCX $0.38
  • Average True Range (ATR)
  • RDHL 0.37
  • CTCX 0.04
  • MACD
  • RDHL -0.12
  • CTCX -0.00
  • Stochastic Oscillator
  • RDHL 0.00
  • CTCX 20.28

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About CTCX Carmell Corporation

Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.

Share on Social Networks: